解决NSCLC进展的未满足需求,通过二线治疗学的进展来解决这一问题
Kinsley Wang1, Alexis Leyba2, Robert Hsu3
1Department of Medicine, University of Arizona College of Medicine, Phoenix, AZ 85004, USA.
Exploration of targeted anti-tumor therapy
|January 6, 2025
概括
针对非小细胞肺癌 (NSCLC) 的有效的二线疗法是非常重要的,因为治疗耐药性. 新兴的选择,如抗体药物合物和免疫疗法为晚期NSCLC患者提供了新的希望.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 非小细胞肺癌 (NSCLC) 是全球癌症死亡的主要原因,占病例的85%.
- 像免疫疗法和向疗法这样的第一线治疗通常会遇到阻力,从而产生对有效的二线选择的需求.
研究的目的:
- 审查现有和新兴的二线治疗方案,以治疗晚期或转移性NSCLC.
- 评估这些疗法的疗效和潜力,以改善患者的治疗结果.
主要方法:
- 对NSCLC的二线治疗现有文献的综述.
- 对抗血管性药物,抗体药物合物 (ADC),CAR-T细胞疗法,T细胞受体疗法和mRNA疫苗的疗效数据的分析.
- 探索分子测试和瘤微环境研究的进展.
主要成果:
- 抗血管性药物 (例如,拉穆西鲁马布与多塞塔塞尔) 显示中等成功.
- ADCs,CAR-T细胞疗法,T细胞受体疗法和mRNA疫苗代表了有希望的向和基于免疫的方法.
- 分子检测,液体活检和了解瘤微环境 (例如,中性粒细胞,巨细胞,Smad3) 是个性化治疗的关键.
结论:
- 新兴疗法,如ADCs和双特异性抗体正在获得引力,但需要更好的生物标志物以获得最佳反应.
- 通过先进的分子测试和监测,可以加强针对NSCLC的个性化二线治疗.
- 进一步研究药物测序,毒性管理和生物标志物开发对于改善NSCLC患者的治疗结果至关重要.
更多相关视频
09:38Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib
Published on: June 26, 2019
7.8K
10:29Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence
Published on: August 14, 2019
10.5K
相关概念视频
02:57Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
02:50Combination Therapies and Personalized Medicine
4.7K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.7K
02:49Cancer Therapies
7.4K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.4K
02:56Treatment Resistant Cancers
3.2K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.2K
01:27Tumor Immunotherapy
394
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
394
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
7.2K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.2K